| Passed by the House April 18, 2013 Yeas 89 FRANK CHOPP ________________________________________ Speaker of the House of Representatives Passed by the Senate April 12, 2013 Yeas 46 BRAD OWEN ________________________________________ President of the Senate | I, Barbara Baker, Chief Clerk of the House of Representatives of the State of Washington, do hereby certify that the attached is SUBSTITUTE HOUSE BILL 1216 as passed by the House of Representatives and the Senate on the dates hereon set forth. BARBARA BAKER ________________________________________ Chief Clerk | |
| Approved May 8, 2013, 2:14 p.m. JAY INSLEE ________________________________________ Governor of the State of Washington | May 8, 2013 Secretary of State State of Washington |
| State of Washington | 63rd Legislature | 2013 Regular Session |
READ FIRST TIME 02/12/13.
AN ACT Relating to eosinophilia gastrointestinal associated disorders; and creating new sections.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 The department of health shall, using the
procedures and standards set forth in chapter 48.47 RCW, conduct a
sunrise review of the proposal, as set forth in House Bill No. 1216
(2013), requiring health carriers to include formulas necessary for the
treatment of eosinophilia gastrointestinal associated disorders,
regardless of the delivery method of the formula. The department shall
report the results of the review no later than thirty days prior to the
2014 legislative session.
NEW SECTION. Sec. 2 Each carrier shall continue to apply a
timely appeals and grievance process as outlined in RCW 48.43.530 to
ensure medically necessary treatment is available. Expedited appeals
must be completed when a delay in the appeal process could jeopardize
the enrollees' life, health, or ability to regain maximum function.